Literature DB >> 35020822

Factors Associated With Discontinuation of Subspecialty Diabetes Care During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study.

Sarah C Haynes1,2, Tejaswi Kompala3,4, Daniel J Tancredi1,5, Aaron B Neinstein3,6, Stephanie S Crossen1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35020822      PMCID： PMC8914412          DOI： 10.2337/dc21-1360

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years.

Authors:  D J Holmes-Walker; A C Llewellyn; K Farrell
Journal:  Diabet Med       Date:  2007-05-29       Impact factor: 4.359

2.  Outpatient Care Preceding Hospitalization for Diabetic Ketoacidosis.

Authors:  Stephanie S Crossen; Darrell M Wilson; Olga Saynina; Lee M Sanders
Journal:  Pediatrics       Date:  2016-06       Impact factor: 7.124

3.  Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.

Authors:  Sarah C Haynes; Tejaswi Kompala; Aaron Neinstein; Jennifer Rosenthal; Stephanie Crossen
Journal:  J Diabetes Sci Technol       Date:  2021-03-14

4.  Who Is (and Is Not) Receiving Telemedicine Care During the COVID-19 Pandemic.

Authors:  Jonathan H Cantor; Ryan K McBain; Megan F Pera; Dena M Bravata; Christopher M Whaley
Journal:  Am J Prev Med       Date:  2021-03-06       Impact factor: 5.043
  4 in total
  2 in total

1.  Challenges and Opportunities in Using Telehealth for Diabetes Care.

Authors:  Stephanie S Crossen; Brittany S Bruggeman; Michael J Haller; Jennifer K Raymond
Journal:  Diabetes Spectr       Date:  2022-02-08

Review 2.  Pediatric Telemedicine: Lessons Learned During the Coronavirus Disease 2019 Pandemic and Opportunities for Growth.

Authors:  Sarah C Haynes; James P Marcin
Journal:  Adv Pediatr       Date:  2022-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.